Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ho Bae

Showing results (781-790 of 809) with videos related to

Pageof 81
Sort By:
Journal of Hepatology|May 15, 2018
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infectionKosh Agarwal, Maurizia Brunetto, Wai Kay Seto, et al.
Hypertension (Dallas, Tex. : 1979)|February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCTJeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.
Lancet (London, England)|March 17, 2018
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trialJoo-Yong Hahn, Young Bin Song, Ju-Hyeon Oh, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trialJung-Min Ahn, Duk-Woo Park, Young-Hak Kim, et al.
Korean Circulation Journal|May 30, 2015
Additive beneficial effects of valsartan combined with rosuvastatin in the treatment of hypercholesterolemic hypertensive patientsJi-Yong Jang, Sang-Hak Lee, Byung Soo Kim, et al.
The American Journal of Cardiology|June 30, 2011
Management of non-ST-segment elevation acute myocardial infarction in patients with chronic kidney disease (from the Korea Acute Myocardial Infarction Registry)Daisuke Hachinohe, Myung Ho Jeong, Shigeru Saito, et al.
Yonsei Medical Journal|December 8, 2017
Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study)Keun Ho Park, Myung Ho Jeong, Young Joon Hong, et al.
Heart and Vessels|July 2, 2024
Balloon-expandable cobalt chromium stent versus self-expandable nitinol stent for the Atherosclerotic Iliac Arterial Disease (SENS-ILIAC Trial) Trial: a randomized controlled trialWoong Gil Choi, Seung-Woon Rha, Byoung Geol Choi, et al.
Journal of Korean Medical Science|November 10, 2010
Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitorJung Sun Cho, Sung-Ho Her, Ju Yeal Baek, et al.
Journal of Korean Medical Science|November 23, 2013
A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE studyUng Kim, Chan-Hee Lee, Jung-Hwan Jo, et al.
Pageof 81

Showing results (781-790 of 809) with videos related to

Sort By:
Pageof 81
Journal of Hepatology|May 15, 2018
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infectionKosh Agarwal, Maurizia Brunetto, Wai Kay Seto, et al.
Hypertension (Dallas, Tex. : 1979)|February 20, 2026
Low-Dose TEL/AML/CHTD SPC Versus Standard-Dose TEL in Hypertension: Phase III RCTJeong Cheon Ahn, Cheol Whan Lee, Jong Hwa Ahn, et al.
Lancet (London, England)|March 17, 2018
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trialJoo-Yong Hahn, Young Bin Song, Ju-Hyeon Oh, et al.
Circulation. Cardiovascular Interventions|October 11, 2012
Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trialJung-Min Ahn, Duk-Woo Park, Young-Hak Kim, et al.
Korean Circulation Journal|May 30, 2015
Additive beneficial effects of valsartan combined with rosuvastatin in the treatment of hypercholesterolemic hypertensive patientsJi-Yong Jang, Sang-Hak Lee, Byung Soo Kim, et al.
The American Journal of Cardiology|June 30, 2011
Management of non-ST-segment elevation acute myocardial infarction in patients with chronic kidney disease (from the Korea Acute Myocardial Infarction Registry)Daisuke Hachinohe, Myung Ho Jeong, Shigeru Saito, et al.
Yonsei Medical Journal|December 8, 2017
Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study)Keun Ho Park, Myung Ho Jeong, Young Joon Hong, et al.
Heart and Vessels|July 2, 2024
Balloon-expandable cobalt chromium stent versus self-expandable nitinol stent for the Atherosclerotic Iliac Arterial Disease (SENS-ILIAC Trial) Trial: a randomized controlled trialWoong Gil Choi, Seung-Woon Rha, Byoung Geol Choi, et al.
Journal of Korean Medical Science|November 10, 2010
Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitorJung Sun Cho, Sung-Ho Her, Ju Yeal Baek, et al.
Journal of Korean Medical Science|November 23, 2013
A prospective, randomized comparison of promus everolimus-eluting and TAXUS Liberte paclitaxel-eluting stent systems in patients with coronary artery disease eligible for percutaneous coronary intervention: the PROMISE studyUng Kim, Chan-Hee Lee, Jung-Hwan Jo, et al.
Pageof 81